Lindsey R. Sangaralingham, MPH
Articles
July 19th 2016
Paul Y. Takahashi, MD Herbert C. Heien, MS Lindsey R. Sangaralingham, MPH Nilay D. Shah, PhD James M. Naessens, ScD
An enhanced risk model incorporating medication use, prior healthcare utilization, and mental health with comorbid health conditions predicts healthcare utilization better than health conditions alone.
June 16th 2016
Adoption of New Agents and Changes in Treatment Patterns for Hepatitis C: 2010-2014
Xiaoxi Yao, PhD Lindsey R. Sangaralingham, MPH Joseph S. Ross, MD Nilay D. Shah, PhD Jayant A. Talwalkar, MD
New hepatitis C medications have been quickly adopted into practice and increased treatment rate. The median out-of-pocket costs of new medications were relatively low.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 19th 2024 | Updated: November 21st 2024
Institute for Value-Based Medicine®: Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes
